Skip to content
← Back to this collection

PUBLICATIONS · 29072975

Dabrafenib and Trametinib Treatment in Patients With Locally Advanced or Metastatic BRAF V600-Mutant Anaplastic Thyroid Cancer.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2018 Jan 1
First author
Subbiah V

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Subbiah V
      type
      Author
    2. name
      Kreitman RJ
      type
      Author
    3. name
      Wainberg ZA
      type
      Author
    4. name
      Cho JY
      type
      Author
    5. name
      Schellens JHM
      type
      Author
    6. name
      Soria JC
      type
      Author
    7. name
      Wen PY
      type
      Author
    8. name
      Zielinski C
      type
      Author
    9. name
      Cabanillas ME
      type
      Author
    10. name
      Urbanowitz G
      type
      Author
    11. name
      Mookerjee B
      type
      Author
    12. name
      Wang D
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Subbiah V
      type
      Author
    2. name
      Kreitman RJ
      type
      Author
    3. name
      Wainberg ZA
      type
      Author
    4. name
      Cho JY
      type
      Author
    5. name
      Schellens JHM
      type
      Author
    6. name
      Soria JC
      type
      Author
    7. name
      Wen PY
      type
      Author
    8. name
      Zielinski C
      type
      Author
    9. name
      Cabanillas ME
      type
      Author
    10. name
      Urbanowitz G
      type
      Author
    11. name
      Mookerjee B
      type
      Author
    12. name
      Wang D
      type
      Author
    bibliography ids
    1. nci-bib-dae6fab4a40e9dc3909d8d62
    book metadata
    content sha256
    157f453a18de5f87512aeaa8e7a9a79898adc558336e72a6f17930325573cfd0
    document type
    citation
    dois
    1. 10.1200/JCO.2017.73.6785
    electronic publication date
    display
    2017 Oct 26
    precision
    day
    year
    2017
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:29072975
    immutable id
    pubmed:29072975@157f453a18de5f87512aeaa8e7a9a79898adc558336e72a6f17930325573cfd0
    journal
    abbreviation
    J Clin Oncol
    issn electronic
    1527-7755
    issn print
    0732-183X
    issue
    1
    name
    Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    nlm unique id
    8309333
    pages
    7-13
    volume
    36
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      29072975
      provenance
      batch id
      fb25b16edcb1373b70c1
      provider
      NCBI PubMed ESummary
      record sha256
      0aaf06734bda8acab99eecc9247c8b5867bb5a6f420af9b0da95d6f0664a33de
      response sha256
      182c99bf1974b58308315b66aa28d31c61e8fc31cf3de4cadb0340a4f6734c52
      retrieved at
      2026-09-09T23:47:28.490065+00:00
      publication date
      display
      2018 Jan 1
      precision
      day
      year
      2018
      publication types
      1. Clinical Trial, Phase II
      2. Journal Article
      3. Multicenter Study
      4. Research Support, N.I.H., Extramural
      5. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/29072975/
      title
      Dabrafenib and Trametinib Treatment in Patients With Locally Advanced or Metastatic BRAF V600-Mutant Anaplastic Thyroid Cancer.

      Preserved source evidence · Not medical advice